MiR-135a promotes the apoptosis of classical Hodgkin lymphoma by mediating downregulated expression of Janus kinase 2 (JAK2) and decreasing the anti-apoptotic gene Bcl-xl (BCL2L1) expression [10]. This evidence concerns the gene JAK2 and Hodgkins lymphoma.